Protein-based embolic agent loaded with ethiodized oil for targeted tumor vascular embolization

Area of Science:

• Biomaterials Science
• Nanotechnology
• Oncology

Background:

• Tumor embolization therapy presents challenges in procedural complexity and imaging guidance.
• Existing embolic agents have limitations that necessitate innovative solutions.

Purpose of the Study:

• To develop a novel protein-based embolic agent for targeted tumor embolization.
• To leverage physiological aggregation processes for enhanced nanoparticle performance.

Main Methods:

• Development of ethiodized oil bound human serum albumin nanoparticles (Oil@HSA NPs).
• Investigation of Oil@HSA NP aggregation and size growth at high concentrations.
• Combination therapy with bacterium-induced coagulation for selective tumor accumulation.

Main Results:

• Oil@HSA NPs exhibit spontaneous aggregation and size growth, surpassing conventional nanoparticles.
• Selective accumulation of Oil@HSA NPs at tumor sites was achieved.
• Significant inhibition of tumor growth was observed due to blocked blood flow.

Conclusions:

• Ethiodized oil bound human serum albumin nanoparticles (Oil@HSA NPs) provide a practical and innovative approach to tumor embolization.
• This method offers a streamlined and effective alternative for vascular targeting in cancer therapy.
• The study highlights a promising strategy for improving cancer treatment outcomes.